Dr. Oral Alpan, MD

Dr. Alpan practices at O & O Alpan in Fairfax, Virginia.

Dr. Alpan's NPI, 1881788610, was assigned on October 3, 2006. Dr. Alpan holds Virginia license 0101238213.

Dr. Alpan's primary practice is O & O Alpan, at 11212 Waples Mill Rd, Fairfax, VA 22030. The practice phone is (240) 643-6002.

Dr. Alpan's primary practice is O & O Alpan in Fairfax, Virginia. Dr. Alpan is also affiliated with Reston Hospital Center. The medical group on file is Amerimmune Clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alpan practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Alpan's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Alpan is licensed in Virginia.

CMS data shows 15,758 Medicare services from Dr. Alpan across 8 procedure codes in 2024, for 209 Medicare patients. Medicare paid $390,139 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Dr. Alpan in 2024. The largest group is 65 to 74, with 103 patients. 73% of them have high cholesterol, and 57% have high blood pressure. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alpan's median patient age at 37, with 64% women.

In 2024, Dr. Alpan wrote 717 Medicare Part D claims for 79 patients. 54% of them were for generic drugs. CMS names the drug for 535 of them, across 17 drugs with 11 or more claims each, at $1,023,605 in total drug cost. In 2023, CMS named 460 claims across 15 drugs.

Dr. Alpan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alpan as offering telehealth.

Dmand AI links 35 papers to Dr. Alpan, published from 2012 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Flow Cytometry, Basophils and Antibodies, Anti-Idiotypic. Dr. Alpan has published most often in Allergy. Dr. Alpan's most frequent co-authors are Ozlem Goker-Alpan, MD, Richard Lawrence Wasserman, MD, PhD and Benjamin Isaac Enav, MD.

Dmand AI links Dr. Alpan to 8 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Immunologic Deficiency Syndromes, Primary Immunodeficiency Diseases and Bruton type agammaglobulinemia. ADMA Biologics, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Alpan that name 4 trials.

CMS Open Payments shows 665 general payments to Dr. Alpan from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Genentech, Inc. paid the most, $34,839. It also lists 12 research payments totaling $91,855 from 2016 to 2022, naming 4 clinical trials.